SITC Archive Library

2016 Community Oncology Conference: Cancer Immunotherapy by Checkpoints and Noncheckpoints 
April 2016
Orlando, FL

Program Overview
In this slide presentation from the April 2016 Community Oncology Conference in Orlando FL, Dr. John Powderly, MD (President, Carolina BioOncology Institute, PLLC; Adjunct Clinical Assistant Professor Medicine Duke & UNC) overviews the application of immune checkpoint inhibitors in several cancer types. His presentation includes a discussion of: Background & History Immunotherapy; Pharmacologic Self Tolerance Blockade; Correlates, Predictors, Biomarkers; New Immunotherapies (checkpoint & noncheckpoint).

Disclaimer: Due to the rapidly-evolving field of cancer immunotherapy, some of the content on this page may be out of date. For current information from SITC on cancer immunotherapy, scroll down to view Related Entries and Links.

#PrimaryCarePhysician #Pharmacist #RegisteredNurse #Oncologist #Researcher #AlliedHealth #Biomarkers
#LungCancers #Non-SmallCellLungCancer #Melanoma #RenalCellCarcinoma #PresentationSlides
#ImmuneCheckpointInhibitors #Ipilimumab #Nivolumab #Pembrolizumab

SITC Cancer Immunotherapy Guidelines https://www.sitcancer.org/research/cancer-immunotherapy-guidelines
Journal for ImmunoTherapy of Cancer https://jitc.biomedcentral.com/articles
Patient Resource Guides https://www.sitcancer.org/connectedold/patient